Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$965K Sell
18,818
-2,559
-12% -$123K 0.2% 58
2022
Q3
$942K Sell
21,377
-15,774
-42% -$766K 0.2% 63
2022
Q2
$1.11M Buy
37,151
+32,030
+625% +$1.63M 0.19% 62
2022
Q1
$266K Sell
5,121
-758
-13% -$39.3K 0.04% 188
2021
Q4
$349K Sell
5,879
-950
-14% -$47.1K 0.04% 185
2021
Q3
$297K Buy
6,829
+1,529
+29% +$67.7K 0.04% 193
2021
Q2
$208K Buy
+5,300
New +$206K 0.03% 216
2019
Q3
Sell
-16,568
Closed -$678K 197
2019
Q2
$678K Sell
16,568
-1,259
-7% -$50K 0.13% 109
2019
Q1
$717K Buy
17,827
+7,206
+68% +$289K 0.16% 102
2018
Q4
$439K Buy
+10,621
New +$441K 0.13% 108

Other funds holding PFE

F3Logic's PFE Position: Q4 2022 in Review

F3Logic reduced its Pfizer (PFE) stake by 12% in Q4 2022, selling an estimated $123K and leaving 18,818 shares worth $965K. The position accounts for 0.2% of the portfolio, ranked #58.

F3Logic first reported a position in PFE in Q4 2018 and has held it in 10 quarters since. The position peaked at $1.11M in Q2 2022. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • F3Logic held 18,818 shares of Pfizer worth $965K as of Q4 2022.
  • F3Logic sold 2,559 Pfizer shares in Q4 2022, an estimated $123K.
  • Pfizer made up 0.2% of F3Logic's portfolio in Q4 2022, its #58 holding.
  • F3Logic first reported a position in Pfizer in Q4 2018 and has held it in 10 quarters since.
  • F3Logic's Pfizer position peaked at $1.11M in Q2 2022.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on F3Logic's 13F filing for Q4 2022, filed 14 Feb 2023.